Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix

International Journal of Gynecological Cancer

Volumn 18, Issue 1, 2008, Pages 80-84

  Uno, T ^a   Mitsuhashi, A ^a   Isobe, K ^a   Yamamoto, S ^a   Kawakami, H ^a   Ueno, N ^a   Usui, H ^a   Tate, S ^a   Kawata, T ^a   Ito, H ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Carcinoma of the cervix; Concurrent cisplatin; Extended field radiation therapy; Para aortic lymph node

Indexed keywords

CISPLATIN; CREATININE;

ADULT; ANEMIA; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; FEASIBILITY STUDY; FEMALE; HUMAN; LEUKOPENIA; LOW DRUG DOSE; NAUSEA; PRIORITY JOURNAL; RADIATION DOSE; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT INDICATION; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA; VOMITING;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 38049088204     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00960.x     Document Type: Article

References (23)

1. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999 340 : 1137 43.
2. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999 340 : 1144 53.
3. Keys HM, Bundy BN, Stehman F et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999 340 : 1154 61.
4. Whitney CW, Sause W, Bundy BN et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999 17 : 1339 48.
5. Eifel PJ, Winter K, Morris M et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004 22 : 872 80.
6. Green JA, Kirwan JM, Tierney JF et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001 358 : 781 6.
7. Lukka H, Hirte H, Fyles A et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer - meta-analysis. Clin Oncol 2002 14 : 203 12.
8. Berman ML, Keys H, Creasman W et al. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes [a Gynecologic Oncology Group study]. Gynecol Oncol 1984 19 : 8 16.
9. Rotman M, Pajak TF, Choi K et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stage IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 1995 274 : 387 93.
10. Malfetano JH, Keys H, Cunningham MJ et al. Extended field radiation and cisplatin for stage IIB and IIIB cervical carcinoma. Gynecol Oncol 1997 67 : 203 7.
11. Varia MA, Bundy BN, Deppe G et al. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1998 42 : 1015 23.
12. Mitsuhashi A, Uno T, Tanaka N et al. Phase I study of daily cisplatin and concurrent radiotherapy in patients with cervical carcinoma. Gynecol Oncol 2005 96 : 194 7.
13. Grigsby PW, Heydon K, Mutch DG et al. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 2001 51 : 982 7.
14. Sood BM, Timmins PF, Gorla GR et al. Concomitant cisplatin and extended field radiation therapy in patients with cervical and endometrial cancer. Int J Gynecol Cancer 2002 12 : 459 64.
15. Grigsby PW, Lu JD, Mutch DG et al. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: phase II study of the Radiation Therapy Oncology Group 92-10. Int J Radiat Oncol Biol Phys 1998 41 : 817 22.
16. Chung Y-L, Jian JJ, Cheng SH et al. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study. Gynecol Oncol 2005 97 : 126 35.
17. Ang KK. Concurrent radiation chemotherapy for locally advanced head and neck carcinoma: are we addressing burning subjects? J Clin Oncol 2004 22 : 4657 9.
18. Portelance L, Chao KS, Grigsby PW et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001 51 : 261 6.
19. Salama JK, Mundt AJ, Roeske J et al. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys 2006 65 : 1170 6.
20. Gerszten K, Colonello K, Heron DE et al. Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. Gynecol Oncol 2006 102 : 182 8.
21. van den Berg HA, Olofsen-van Acht MJJ, van Santvoort JP et al. Definition and validation of a reference target volume in early stage node-positive cervical carcinoma, based on lymphangiograms and CT-scans. Radiother Oncol 2000 54 : 163 70.
22. Chao KS, Lin M. Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002 54 : 1147 52.
23. Taylor A, Rockall AG, Reznek RH et al. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005 63 : 1604 12.